FDA's Proposed GTP Rule Requires Tracking Of Tissue Combination Devices
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers of devices that incorporate human cells or tissue will be required to track their products under a "current Good Tissue Practices" proposed rule published in the Federal Register Jan. 8.